Understanding peptide purity

Purity is a measurement, not an absolute

Peptide purity is frequently reduced to a single percentage, but that number only has meaning when the analytical method behind it is understood. In most peptide certificates, purity is reported from reversed-phase HPLC or UHPLC using ultraviolet detection. The sample is separated into chromatographic peaks and software integrates the detector response. A statement such as “99.2% purity by HPLC” normally means that approximately 99.2% of the integrated signal included in the calculation was assigned to the principal chromatographic peak under the stated method conditions. It does not automatically mean that 99.2% of the physical mass in the vial is peptide.

What HPLC may not capture

That distinction matters because HPLC-UV detects compounds according to how strongly they absorb at the selected wavelength. Peptide bonds absorb strongly at low ultraviolet wavelengths, while aromatic residues contribute at higher wavelengths. Water, many inorganic salts and some counter-ions may produce little or no response under the chosen conditions. Residual moisture, acetate, trifluoroacetate, buffer salts and other non-volatile material can therefore contribute to vial mass without being represented proportionally in a peak-area purity result. Conversely, an impurity with a strong chromophore may generate more detector response per unit mass than the target peptide.

Why methods give different answers

Purity is also method-dependent. Column chemistry, mobile-phase composition, gradient slope, temperature, flow rate, detector wavelength and integration settings all influence how effectively related species are separated and how peak area is assigned. A method that resolves deletion sequences, oxidation products or closely related isomers may report a lower but more informative purity than a less discriminating method that merges them into the main peak. For that reason, comparing headline percentages from different laboratories is weak unless the analytical conditions and reporting rules are broadly comparable.

Where peptide impurities come from

Peptide impurities can arise from synthesis, cleavage, deprotection, purification and storage. Solid-phase synthesis may generate deletion sequences when a coupling step is incomplete, truncated products if chain extension stops prematurely, or modified species from side reactions. Oxidation-prone residues such as methionine and tryptophan, deamidation-prone residues such as asparagine and glutamine, and disulfide-forming cysteines can produce additional species during processing or storage. HPLC can reveal many of these as separate peaks, but it does not identify them unless combined with another technique.

Complementary analytical tests

A strong purity statement therefore sits beside identity data. LC-MS, MALDI-TOF or another mass-spectrometric approach can show whether the principal peak has a mass consistent with the expected sequence. Additional assays may be required when the total composition matters: Karl Fischer titration for water, ion chromatography for counter-ions, gas chromatography for residual

solvents, elemental analysis, amino-acid analysis or quantitative assays using a reference standard. These methods answer questions that a chromatographic area percentage cannot.

How to read a purity statement

When reading a certificate, look for the method name, chromatogram, detector wavelength or detector type, sample or injection details, date, batch number and explicit result. The best interpretation is precise: “the batch showed X% main-peak area by the stated HPLC method.” That wording is technically stronger than treating “purity” as an absolute property divorced from method. A high number can be useful evidence of chromatographic homogeneity, but it should be read as one component of a broader analytical picture rather than as a complete statement of vial composition.